STOCK TITAN
  1. Home
  2. Sec-filings
  3. ULTA
  4. [Form 4] Ulta Beauty, Inc. Insider Trading Activity

Ulta Beauty (ULTA) CFO awarded stock options and restricted shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ulta Beauty’s Chief Financial Officer Christopher DelOrefice received new equity awards as part of his compensation. He was granted 4,219 shares of restricted stock that vest 100% on March 15, 2029, giving him more direct ownership over time.

He was also granted stock options covering 14,363 shares of common stock at an exercise price of $522.71 per share. These options vest in 25% annual increments beginning March 15, 2027 and on each anniversary through March 15, 2030, and expire on March 31, 2036. Following the grants, he directly holds 9,693 shares of common stock, plus the new option award.

Positive

  • None.

Negative

  • None.
Insider DelOrefice Christopher
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 14,363 $0.00 --
Grant/Award Common Stock 4,219 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 14,363 shares (Direct); Common Stock — 9,693 shares (Direct)
Footnotes (1)
  1. Represents grant of 4,219 shares of restricted stock, vesting 100% on March 15, 2029. The options, representing an initial right to purchase a total of 14,363 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.
Restricted stock grant 4,219 shares Vests 100% on March 15, 2029
Option grant size 14,363 shares Stock options on common stock
Option exercise price $522.71/share Exercise price for 14,363 stock options
Option vesting start March 15, 2027 First 25% of options vest
Option vesting completion March 15, 2030 Final 25% of options vest
Option expiration March 31, 2036 Expiration date of option grant
Shares held after grant 9,693 shares Common stock directly owned after restricted stock grant
restricted stock financial
"Represents grant of 4,219 shares of restricted stock, vesting 100% on March 15, 2029."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Stock Option (right to buy financial
"Stock Option (right to buy) with an initial right to purchase 14,363 shares."
vesting financial
"The options ... vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price of 522.7100 for the stock options."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DelOrefice Christopher
(Last)(First)(Middle)
1000 REMINGTON BLVD., SUITE 120
(Street)
BOLINGBROOK ILLINOIS 60440
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Ulta Beauty, Inc. [ ULTA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026A4,219(1)A$09,693D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$522.7103/31/2026A14,363 (2)03/31/2036Common Stock14,363$014,363D
Explanation of Responses:
1. Represents grant of 4,219 shares of restricted stock, vesting 100% on March 15, 2029.
2. The options, representing an initial right to purchase a total of 14,363 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.
/s/ Rene G. Casares, as attorney-in-fact for Christopher DelOrefice04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Ulta Beauty (ULTA) disclose about its CFO in this Form 4?

The filing shows CFO Christopher DelOrefice received new equity awards, not open-market trades. He was granted 4,219 restricted shares and options for 14,363 shares, reflecting compensation-based incentives aligned with Ulta Beauty’s stock performance over several years.

How many restricted shares did Ulta Beauty’s CFO receive and when do they vest?

He received 4,219 shares of restricted stock, vesting 100% on March 15, 2029. This single cliff-vesting date means he must remain in his role until then to receive the full award as unrestricted common stock.

What stock options were granted to Ulta Beauty (ULTA) CFO Christopher DelOrefice?

He was granted options to purchase 14,363 shares of Ulta Beauty common stock at an exercise price of $522.71 per share. The options expire on March 31, 2036, providing a long-term incentive tied directly to future share price performance.

How do the Ulta Beauty CFO stock options vest over time?

The options vest in 25% annual increments beginning March 15, 2027, then on each anniversary through March 15, 2030. This four-year schedule encourages the CFO’s continued service and aligns his incentives with multi‑year company performance.

How many Ulta Beauty common shares does the CFO hold after these grants?

After the grants, Christopher DelOrefice directly holds 9,693 shares of Ulta Beauty common stock. This reflects his post-transaction ownership position and does not include the 14,363 shares underlying the newly granted options until they are exercised.

Are the Ulta Beauty CFO transactions in this Form 4 open-market buys or sells?

No, both transactions are classified as grants or awards, not open-market trades. The restricted stock and stock options represent compensation-based equity awards, rather than discretionary buying or selling of Ulta Beauty shares in the market.